Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma

We present our initial experience in using single modality fluoromisonidazole (FMISO) PET/MR imaging to noninvasively evaluate the biological effects induced by bevacizumab therapy in a patient treated for recurrent high grade glioma. In this index patient, bevacizumab therapy resulted in the develo...

Full description

Bibliographic Details
Main Authors: Ramon F. Barajas, Miguel H. Pampaloni, Jennifer L. Clarke, Youngho Seo, Dragana Savic, Randall A. Hawkins, Spencer C. Behr, Susan M. Chang, Mitchel Berger, William P. Dillon, Soonmee Cha
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Case Reports in Radiology
Online Access:http://dx.doi.org/10.1155/2015/731361

Internet

http://dx.doi.org/10.1155/2015/731361

Similar Items